Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
After finishing at $47.5 in the prior trading day, Revolution Medicines Inc (NASDAQ: RVMD) closed at $49.56, up 4.34%. In other words, the price has increased by $4.34 from its previous closing price. On the day, 2.3 million shares were traded. RVMD stock price reached its highest trading level at $49.825 during the session, while it also had its lowest trading level at $47.45.
Ratios:
Our goal is to gain a better understanding of RVMD by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.79 and its Current Ratio is at 11.79. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
On September 05, 2025, Truist started tracking the stock assigning a Buy rating and target price of $99.
On August 19, 2025, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $75.Piper Sandler initiated its Overweight rating on August 19, 2025, with a $75 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 13 ’25 when Kelsey Stephen Michael sold 25,000 shares for $48.54 per share. The transaction valued at 1,213,540 led to the insider holds 284,047 shares of the business.
Cislini Jeff sold 1,799 shares of RVMD for $79,624 on Sep 24 ’25. The General Counsel now owns 50,425 shares after completing the transaction at $44.26 per share. On Sep 24 ’25, another insider, JEFFREY TODD CISLINI, who serves as the Officer of the company, bought 1,799 shares for $44.21 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RVMD now has a Market Capitalization of 9264408576 and an Enterprise Value of 7260024832.
Stock Price History:
The Beta on a monthly basis for RVMD is 1.23, which has changed by -0.050000012 over the last 52 weeks, in comparison to a change of 0.14201736 over the same period for the S&P500. Over the past 52 weeks, RVMD has reached a high of $62.40, while it has fallen to a 52-week low of $29.17. The 50-Day Moving Average of the stock is 18.87%, while the 200-Day Moving Average is calculated to be 24.29%.
Shares Statistics:
The stock has traded on average 1.98M shares per day over the past 3-months and 1961980 shares per day over the last 10 days, according to various share statistics. A total of 186.90M shares are outstanding, with a floating share count of 162.03M. Insiders hold about 13.32% of the company’s shares, while institutions hold 91.87% stake in the company. Shares short for RVMD as of 1759190400 were 17968076 with a Short Ratio of 9.07, compared to 1756425600 on 16527230. Therefore, it implies a Short% of Shares Outstanding of 17968076 and a Short% of Float of 10.229999600000001.
Earnings Estimates
The stock of Revolution Medicines Inc (RVMD) is currently drawing attention from 15.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is -$1.52, with high estimates of -$1.18 and low estimates of -$1.73.
Analysts are recommending an EPS of between -$4.47 and -$5.62 for the fiscal current year, implying an average EPS of -$5.31. EPS for the following year is -$6.01, with 16.0 analysts recommending between -$4.47 and -$7.69.
